While the quarter itself was fine, the guidance the glass maker provided to the Street on the outlook for 2012 and beyond was refreshingly frank but clearly disappointing to investors.
Merck did fine here, with many years as the only maker of an integrase inhibitor, but it does seem the companies following in its wake may have an easier time.
Happily, though, Synaptics says that's something it's able to fine-tune, depending on whether a PC maker wants a firmer keyboard or something a bit softer. (We say the market has enough flat, lifeless Ultrabook keyboards, but that's just us.) In any case, we hope to test a more polished keyboard sometime later -- one that has all those additional touch-sensitive features enabled.